Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma.

European journal of gastroenterology & hepatology - 1 Nov 2018

Abdelaziz Ashraf O, Shousha Hend I, Said Ebada M, Soliman Zeinab A, Shehata Ahmed A, Nabil Mohamed M, Abdelmaksoud Ahmed H, Elbaz Tamer M, Abdelsalam Fatma M

Abstract excerpt

INTRODUCTION: Steatosis is a documented feature of chronic hepatitis C (CHC). There is an association between steatosis decrease and fibrosis progression. The association between steatosis and advanced fibrosis versus hepatocellular carcinoma (HCC) development has not been precisely evaluated. The controlled attenuation parameter (CAP) was applied as an immediate and efficient process to detect and quantify...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Egypt

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Elasticity Imaging Techniques

Share to Hepatitis C, Chronic

Share to Liver Cirrhosis

Share to Liver Neoplasms

Share to Non-alcoholic Fatty Liver Disease

Share to Predictive Value of Tests

Source

Identifiers

PMID: 30179227
DOI: 10.1097/MEG.0000000000001196

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma.PMID 30179227Read ↗

Hepatitis C and steatosis.Semantic proximity Read ↗

Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside.Semantic proximity Read ↗

Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients.Semantic proximity Read ↗

The association between serum uric acid and controlled attenuation parameter in United States adults without hepatitis B and C: a cross-sectional studySemantic proximity Read ↗

Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1b.Semantic proximity Read ↗

Noninvasive characterization of graft steatosis after liver transplantation.Semantic proximity Read ↗

Detection of hepatic steatosis with ultrasound attenuation imaging compared to MRISemantic proximity Read ↗

Persistent steatosis retards fibrosis regression during anti-HBV treatment in patients with chronic HBV infectionSemantic proximity Read ↗

Hepatic steatosis and hepatitis C: Still unhappy bedfellows?Semantic proximity Read ↗

Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population.Semantic proximity Read ↗

Hepatitis B: liver fibrosis and hepatocellular carcinoma.Semantic proximity Read ↗

Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.